Loading...
FAK Inhibition Decreases Hepatoblastoma Survival Both In Vitro and In Vivo
Hepatoblastoma is the most frequently diagnosed liver tumor of childhood, and children with advanced, metastatic or relapsed disease have a disease-free survival rate under 50%. Focal adhesion kinase (FAK) is a nonreceptor tyrosine kinase that is important in many facets of tumor development and pro...
Saved in:
Main Authors: | , , , , , |
---|---|
Format: | Artigo |
Language: | Inglês |
Published: |
Neoplasia Press Inc.
2013
|
Subjects: | |
Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3610546/ https://ncbi.nlm.nih.gov/pubmed/23544173 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|